A Study to Evaluate the Pharmacokinetics of Tezepelumab After Being Delivered by an Accessorized Pre Filled Syringe or Autoinjector Compared With Vial and Syringe in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

315

Participants

Timeline

Start Date

June 19, 2019

Primary Completion Date

December 30, 2019

Study Completion Date

December 30, 2019

Conditions

Asthma

Interventions

BIOLOGICAL

Tezepelumab

Tezepelumab subcutaneous injection

Trial Locations (1)

Research Site, Berlin